Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment

Cancer Research

Volumn 66, Issue 3, 2006, Pages 1337-1345

  Waalkes, Michael P ^a   Liu, Jie ^a   Ward, Jerrold M ^b   Powell, Douglas A ^c   Diwan, Bhalchandra A ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENITE SODIUM; CARCINOGEN; DIETHYLSTILBESTROL; DRINKING WATER; ESTROGEN RECEPTOR ALPHA; TAMOXIFEN;

ADRENAL CORTEX ADENOMA; ANIMAL MODEL; ARTICLE; AUTOPSY; BENIGN TUMOR; BLADDER TUMOR; CANCER INCIDENCE; CARCINOGENICITY; CONTROLLED STUDY; DATA ANALYSIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; OVARY TUMOR; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT CANCER; UTERINE CERVIX TUMOR; UTERUS TUMOR;

ANIMALS; ARSENIC; BODY WEIGHT; DIETHYLSTILBESTROL; DRINKING; DRUG SYNERGISM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; GENITAL NEOPLASMS, FEMALE; KIDNEY NEOPLASMS; MATERNAL-FETAL EXCHANGE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TAMOXIFEN; URINARY BLADDER NEOPLASMS; UTERUS;

EID: 32944464477     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3530     Document Type: Article

References (38)

1. National Research Council. Arsenic in the drinking water. Washington (District of Columbia): National Academy Press; 1999. p. 1-310.
2. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 1995;141:198-209.
3. Yoshida T, Yamauchi H, Sun GF. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 2004;198:243-52.
4. Ferreccio C, Gonzalez C, Milosavlevic V, et al. Lung cancer and arsenic concentrations in drinking water in Chue. Epidemiol 2000;11:673-9.
5. Rossman TG, Uddin AN, Burns FJ, Bosland MC. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol 2001;176:64-71.
6. Germolec DR, Spalding J, Boorman GA, et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 1997;386:209-18.
7. Waalkes MP, Ward JM, Liu J, Diwan, BA. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary and adrenal tumors in mice. Toxicol Appl Pharmacol 2003;186:7-17.
8. Waalkes MP, Ward JM, Diwan BA. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 2004;25:133-41.
9. Wei M, Wanibuchi H, Yamamoto S, Li W, Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 1999;20:1873-6.
10. Li W, Wanibuchi H, Salim EI, et al. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett 1998;134:29-36.
11. Yamamoto S, Konishi Y, Matsuda T, et al. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res 1995;55:1271-6.
12. Marshall FF. Embryology of the lower genitourinary tract. Urol Clin North Am 1978;5:3-15.
13. Kispert A, Gossler A. Introduction to early mouse development In: Hedrick H, editor. The laboratory mouse. Amsterdam (the Netherlands): Elsevier; 2004. p. 175-91.
14. Anderson LM. Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination. Toxicol Appl Pharmacol 2004;199:162-74.
15. Anderson LM, Diwan BA, Fear NT, Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 2000;108:573-94.
16. Watanabe S, Kobayashi Y. Exogenous hormones and cancer. Jpn J Clin Oncol 1993;23:1-13.
17. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000;74:357-64.
18. Newbold RR, Jefferson WN, Padilla-Burgos E, Bullock B. Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis 1997;18:2293-8.
19. Moolgavkar SH. Hormones and multistage carcinogenesis. Cancer Surv 1986;5:635-48.
20. Diwan BA, Anderson LM, Ward JM. Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen. Carcinogenesis 1997;18:2009-14.
21. Noble RL, Hochachka BC, King D. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res 1975;35:766-80.
22. Metzler M, Degen GH. Sex hormones and neoplasia: liver tumors in rodents. Arch Toxicol 1987;10:251-63.
23. Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 2004;199:142-50.
24. Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 2003;111:389-94.
25. Couse JF, Korach KS. Estrogen receptor-α mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract Toxicology 2004;205:55-63.
26. Waalkes MP, Liu J, Chen H, et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 2004;96:466-74.
27. Couse JF, Davis VL, Hanson RB, et al. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrqgen receptor after neonatal exposure to diethylstilbestrol. Mol Carcinog 1997;19:236-42.
28. Waalkes MP, Keefer LK, Diwan BA. Induction of proliferative lesions of the uterus, testes, and liver in Swiss mice given repeated injections of sodium arsenate; Possible estrogenic mode of action. Toxicol Appl Pharmacol 2000;166:24-35.
29. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 2004;25:1779-86.
30. Maita K, Hirano M, Harada T, et al. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol 1988;16:340-9.
31. Son WC, Gopinath C. Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats. Toxicol Pathol 2004;32:317-4.
32. Wolf JC. Characteristics of the spectrum of proliferative lesions observed in the kidney and urinary bladder of Fischer 344 and B6C3F1 mice. Toxicol Pathol 2002;30:657-62.
33. Sun J-M, Spencer VA, Li L, Chen HY, Yu J, Davie JR. Estrogen regulation of trefoil factor 1 expression by estrogen receptor α and Sp proteins. Exp Cell Res 2005;302:96-107.
34. Teng CT, Gladwell W, Beard C, Walmer D, Teng CS, Brenner R. Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium. Mol Hum Reprod 2002;8:58-67.
35. Sueyoshi T, Yokomori N, Korach KS, Negishi M. Developmental action of estrogen receptor-α feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp 2d9 genes in mouse liver. Mol Pharmacol 1999;56:473-7.
36. Cook JD, Davis BJ, Cai SL, Barrett JC, Conti CJ, Walker CL. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A 2005;102:8644-9.
37. Baik I, Becker PS, DeVito WJ, et al. Stem cells and prenatal origin of breast cancer. Cancer Causes Cont 2004;15:517-30.
38. Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mut Res 2004;533:37-65.